Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| UH IRB #07-07-08 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to show that the surgical site in the bowel wall can be sewn closed in the colon or intestine, with a new sewing device after removal of a benign polyp according to standard of care.
Polypectomy is the medical term for removing polyps. Polyps are abnormal like growths that protrude into the lining of the bowel. Because a polyp cannot always be removed by a snare, the usual and simplest method, (for example, it may be too flat), a doctor (colorectal surgeon) may perform a polypectomy using a technique called Endoscopic Mucosal Resection (EMR). Endoscopic Mucosal Resection (EMR)is based on the concept that endoscopy (looking at the inside of your colon with an instrument called a colonoscope) provides visualization and access to the innermost lining of the gastrointestinal tract, where a polyp originates. The Endoscopic Mucosal Resection (EMR)performed during this study will be standard of care according to the current practice at University Hospitals of Cleveland.
Following polyp removal, the study procedure will be performed. A medical device is being evaluated to help with this procedure by closing the wound that remains after the polyp is removed without performing an open surgical operation. This involves suturing (sewing) the tissue back together with a Tissue Apposition System (TAS). This is also called tissue approximation. The sewing device being evaluated has been cleared by the Food and Drug Administration (FDA).
Up to 20 men and women, at least 21 years of age, requiring removal of a colonic or rectal polyp that cannot be removed by traditional colonic polypectomy, will be asked to enroll in the study. Following polyp removal, these patients will have the remaining tissue area closed using the study sewing device. Participation in this study will last approximately three months.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Enrolled Subjects treated with TAS device | Experimental | All enrolled subjects treated with the Tissue Apposition System (TAS) device |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Tissue Apposition System (TAS) Device | Device | Closure of defect following polypectomy using the Tissue Apposition System (TAS) Device. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Numbers of Participants With Successful Deployment of Tissue Apposition System (TAS) | Number of enrolled subjects (participants) treated with successful deployment of the Tissue Apposition System (TAS) device. | At The Time of Surgery |
| Measure | Description | Time Frame |
|---|---|---|
| Numbers of Participants With Successful Deployments of Tissue Anchors and Associated Knotting Element for Tissue Closure Post-Endoscopic Mucosal Resection (EMR) Tissue Apposition. | The total number of participants with successful deployments of tissue anchors and associated knotting elements for tissue closure post-Endoscopic Mucosal Resection (EMR) tissue apposition and achieving defect closure. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Conor P Delaney, MD MCh PhD FRCSI FACS | University Hospitals Cleveland Medical Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University Hospitals, Case Medical Center | Cleveland | Ohio | 44106 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 20438900 | Derived | Agrawal D, Chak A, Champagne BJ, Marks JM, Delaney CP. Endoscopic mucosal resection with full-thickness closure for difficult polyps: a prospective clinical trial. Gastrointest Endosc. 2010 May;71(6):1082-8. doi: 10.1016/j.gie.2009.12.036. |
Not provided
Not provided
Non-randomized. Patients were considered for enrollment based on inclusion / exclusion criteria and were offered the opportunity for enrollment. Those that signed informed consent were enrolled.
Single Center, hospital based surgical suite. Enrollment from 20 August 2007 to 09 April 2009.
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Enrolled Subjects Treated With Tissue Apposition System (TAS) | All enrolled subjects treated with Tissue Apposition System (TAS) device and achieving defect closure |
| Title | Milestones | Reasons Not Completed | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Enrolled Subjects Treated With Tissue Apposition System (TAS) | All enrolled subjects treated with Tissue Apposition System (TAS) device and achieving defect closure |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Categorical | Count of Participants |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Secondary | Numbers of Participants With Successful Deployments of Tissue Anchors and Associated Knotting Element for Tissue Closure Post-Endoscopic Mucosal Resection (EMR) Tissue Apposition. | The total number of participants with successful deployments of tissue anchors and associated knotting elements for tissue closure post-Endoscopic Mucosal Resection (EMR) tissue apposition and achieving defect closure. | Posted | Number | participants | 3 month follow-up |
|
|
3 months
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Enrolled Subjects Treated With Tissue Apposition System (TAS) | All enrolled subjects treated with Tissue Apposition System (TAS) device and achieving defect closure |
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Spinal Stenosis | Musculoskeletal and connective tissue disorders | MedDRA 10.0 | Systematic Assessment | The EMR procedure was performed on 12 March 2008. Two days later, on 14 March 2008, the subject underwent elective spinal surgery for his ongoing stenosis. In the opinion of the PI, this SAE was unrelated to the EMR procedure or TAS. |
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Abdominal Pain | General disorders | MedDRA 10.0 | Systematic Assessment |
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Amy Mahanes, Clinical Research Associate II | Ethicon Endo-Surgery, Inc | 513-337-8366 | amahanes@its.jnj.com |
Not provided
| ID | Term |
|---|---|
| D011127 | Polyps |
| ID | Term |
|---|---|
| D020763 | Pathological Conditions, Anatomical |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 3 month follow-up |
| Number of Participants With Durable Tissue Appositions at Three Months Post-Endoscopic Mucosal Resection (EMR) Tissue Apposition | 3 month follow-up |
| Participants |
|
| Age Continuous | Mean | Standard Deviation | years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Region of Enrollment | Number | participants |
|
| Participants |
|
|
| Secondary | Number of Participants With Durable Tissue Appositions at Three Months Post-Endoscopic Mucosal Resection (EMR) Tissue Apposition | All enrolled subjects were analyzed | Posted | Number | Participants | 3 month follow-up |
|
|
|
| Primary | Numbers of Participants With Successful Deployment of Tissue Apposition System (TAS) | Number of enrolled subjects (participants) treated with successful deployment of the Tissue Apposition System (TAS) device. | All enrolled subjects were analyzed | Posted | Number | participants | At The Time of Surgery |
|
|
|
| 2 |
| 7 |
| 6 |
| 7 |
|
| Chest Pain | Cardiac disorders | MedDRA 10.0 | Systematic Assessment | EMR was performed on 05May2008. On 18May2008, subject had moderate chest pain requiring hospitalization. Following pharmaceutical intervention, resolved without sequelae 3 days after onset. In the opinion of the PI, this SAE was unrelated to TAS. |
|
| Abdominal Tenderness | General disorders | MedDRA 10.0 | Systematic Assessment |
|
| Hypotension | General disorders | MedDRA 10.0 | Systematic Assessment |
|
| scratch | Skin and subcutaneous tissue disorders | MedDRA 10.0 | Systematic Assessment |
|
| hemoglobin low | Blood and lymphatic system disorders | MedDRA 10.0 | Systematic Assessment |
|
| sinus bradycardia | Cardiac disorders | MedDRA 10.0 | Systematic Assessment |
|
| Lymphoid tissue hyperplasia | Blood and lymphatic system disorders | MedDRA 10.0 | Systematic Assessment |
|
| Abdominal cramp | General disorders | MedDRA 10.0 | Systematic Assessment |
|
| blood in stool | Gastrointestinal disorders | MedDRA 10.0 | Systematic Assessment |
|
| dry mouth | Skin and subcutaneous tissue disorders | MedDRA 10.0 | Systematic Assessment |
|
| headache | Nervous system disorders | MedDRA 10.0 | Systematic Assessment |
|
| lower abdominal pain | General disorders | MedDRA 10.0 | Systematic Assessment |
|
| numbness lips | Skin and subcutaneous tissue disorders | MedDRA 10.0 | Systematic Assessment |
|
| Shoulder discomfort | Musculoskeletal and connective tissue disorders | MedDRA 10.0 | Systematic Assessment |
|
| tingling lips | Skin and subcutaneous tissue disorders | MedDRA 10.0 | Systematic Assessment |
|
| pain abdominal | General disorders | MedDRA 10.0 | Systematic Assessment |
|
| granulation tissue | Skin and subcutaneous tissue disorders | MedDRA 10.0 | Systematic Assessment |
|
| pain in toe | Musculoskeletal and connective tissue disorders | MedDRA 10.0 | Systematic Assessment |
|
| atelectasis | Respiratory, thoracic and mediastinal disorders | MedDRA 10.0 | Systematic Assessment |
|
| application site bruise | Skin and subcutaneous tissue disorders | MedDRA 10.0 | Systematic Assessment |
|
| hematoma | Skin and subcutaneous tissue disorders | MedDRA 10.0 | Systematic Assessment |
|
| hypokalemia | Metabolism and nutrition disorders | MedDRA 10.0 | Systematic Assessment |
|
| injection site itching | Skin and subcutaneous tissue disorders | MedDRA 10.0 | Systematic Assessment |
|
| low hemoglobin | Blood and lymphatic system disorders | MedDRA 10.0 | Systematic Assessment |
|
| hypomagnesemia | Metabolism and nutrition disorders | MedDRA 10.0 | Systematic Assessment |
|
| atrial fibrillation | Cardiac disorders | MedDRA 10.0 | Systematic Assessment |
|
| groin pain | Musculoskeletal and connective tissue disorders | MedDRA 10.0 | Systematic Assessment |
|
| abdominal aortic aneurysm | Vascular disorders | MedDRA 10.0 | Systematic Assessment |
|
| low back pain | Musculoskeletal and connective tissue disorders | MedDRA 10.0 | Systematic Assessment |
|
| dry nose | General disorders | MedDRA 10.0 | Systematic Assessment |
|
| RBC low | Blood and lymphatic system disorders | MedDRA 10.0 | Systematic Assessment |
|
| soreness corner of mouth | General disorders | MedDRA 10.0 | Systematic Assessment |
|
| suture line inflammation | Surgical and medical procedures | MedDRA 10.0 | Systematic Assessment |
|
| abdominal bloating | Gastrointestinal disorders | MedDRA 10.0 | Systematic Assessment |
|
| tenderness | General disorders | MedDRA 10.0 | Systematic Assessment |
|
| polyp removal | Surgical and medical procedures | MedDRA 10.0 | Systematic Assessment |
|
Not provided